Abciximab FDA Link

A Fab fragment of the chimeric monoclonal antibody 7E3 that binds to the glycoprotein IIb-IIIa receptor of human platelets, and blocks PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX, potently inhibiting PLATELET AGGREGATION. It is used in treatment of refractory unstable angina, and for prevention of ischemic complications in patients undergoing percutaneous coronary procedures such as ANGIOPLASTY; ATHERECTOMY; or stenting.

Also Known As:

ReoPro; CentoRx; Chimeric 7E3 Fab; Clotinab; c7E3 Fab; Fab, Chimeric 7E3

Amino Acids, Peptides, and Proteins: 1
- Proteins: 496323
  - Blood Proteins: 12679
    - Serum Globulins: 555
      - Immunoglobulins: 30911
        Antibodies: 135587
        Monoclonal Antibodies: 57170
        Humanized Monoclonal Antibodies: 220
        Abciximab: 1222
        Immunoglobulin Fragments: 979
        Immunoglobulin Fab Fragments: 766
        Abciximab: 1222
    - Immunoproteins: 43
      - Immunoglobulins: 30911
        Antibodies: 135587
        Monoclonal Antibodies: 57170
        Humanized Monoclonal Antibodies: 220
        Abciximab: 1222
        Immunoglobulin Fragments: 979
        Immunoglobulin Fab Fragments: 766
        Abciximab: 1222
  - Globulins: 3119
    - Serum Globulins: 555
      - Immunoglobulins: 30911
        Antibodies: 135587
        Monoclonal Antibodies: 57170
        Humanized Monoclonal Antibodies: 220
        Abciximab: 1222
        Immunoglobulin Fragments: 979
        Immunoglobulin Fab Fragments: 766
        Abciximab: 1222
- Peptides: 84029
  - Peptide Fragments: 379
    - Immunoglobulin Fragments: 979
      - Immunoglobulin Fab Fragments: 766
        Abciximab: 1222

R E Raymond Selected Research

R E Raymond Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure